Analyst firms · Citizens JMP · ENTA

Citizens JMP ENTA price target and rating history

Enanta Pharmaceuticals Inc. (ENTA) · Health Care

Citizens JMP rates Enanta Pharmaceuticals Inc. (ENTA) Market Outperform with a $116 price target, as of its latest action on Nov 23, 2021. It has published 5 rating actions on ENTA since August 2021, including 0 upgrades and 0 downgrades.

Current rating
Market Outperform
Price target
$116
Median target, all firms
Too few
Actions on ENTA
5

Citizens JMP price target on ENTA

$121$99$7720222023202420252026
Citizens JMP price target on ENTA, each point a stated target, August 2021 to November 2021.

Every Citizens JMP rating on ENTA

Questions about Citizens JMP and ENTA

What is Citizens JMP's price target for ENTA?
Citizens JMP's latest stated price target for Enanta Pharmaceuticals Inc. (ENTA) is $116, from its action on Nov 23, 2021.
What is Citizens JMP's rating on ENTA?
Citizens JMP rates ENTA Market Outperform, a bullish rating, as of Nov 23, 2021.
When did Citizens JMP last change its view on ENTA?
On Nov 23, 2021, Citizens JMP raises its price target to $116 from $111, keeps Market Outperform.

More ENTA rating histories

All Citizens JMP ratingsENTA news and filingsEvery analyst firm

From rating actions in the Quantisnow feed. A target holds until the firm states a new one; a reiteration with no target keeps the last one. Not investment advice.